HT-29 colorectal cancer cells undergoing apoptosis overexpress COX-2 to delay ursolic acid-induced cell death

Biochimie

Volumn 93, Issue 4, 2011, Pages 749-757

  Limami, Youness ^a   Pinon, Aline ^a   Leger, David Yannick ^a   Mousseau, Yoanne ^a   Cook Moreau, Jeanne ^a   Beneytout, Jean Louis ^a   Delage, Christiane ^a   Liagre, Bertrand ^a   Simon, Alain ^a  

^a UNIVERSITY OF LIMOGES   (France)

Author keywords

Apoptosis resistance; Cyclooxygenase 2; HT 29 colorectal cancer cells; Ursolic acid

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CASPASE 3; CYCLOOXYGENASE 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 14; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTAGLANDIN E2; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; URSOLIC ACID;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER RESISTANCE; CELL PROLIFERATION; CELL STRAIN HCT116; CELL STRAIN HT29; CONTROLLED STUDY; DNA FRAGMENTATION; DRUG MECHANISM; DRUG SENSITIVITY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION;

APOPTOSIS; COLORECTAL NEOPLASMS; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DRUG RESISTANCE, NEOPLASM; HCT116 CELLS; HT29 CELLS; HUMANS; NITROBENZENES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RNA, SMALL INTERFERING; SULFONAMIDES; TRITERPENES;

EID: 79952447295     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2011.01.003     Document Type: Article

References (56)

1. L. Herszenyi, and Z. Tulassay Epidemiology of gastrointestinal and liver tumors Eur. Rev. Med. Pharmacol. Sci. 14 2010 249 258
2. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Global cancer statistics, 2002 CA Cancer J. Clin. 55 2005 74 108 (Pubitemid 40372904)
3. E. Giovannucci, E.B. Rimm, M.J. Stampfer, G.A. Colditz, A. Ascherio, and W.C. Willett Aspirin use and the risk for colorectal cancer and adenoma in male health professionals Ann. Intern. Med. 121 1994 241 246
4. E. Giovannucci, K.M. Egan, D.J. Hunter, M.J. Stampfer, G.A. Colditz, W.C. Willett, and F.E. Speizer Aspirin and the risk of colorectal cancer in women N. Engl. J. Med. 333 1995 609 614
5. M.J. Thun, M.M. Namboodiri, and C.W. Heath Jr. Aspirin use and reduced risk of fatal colon cancer N. Engl. J. Med. 325 1991 1593 1596
6. T.A. Chan Nonsteroidal anti-inflammatory drugs, apoptosis, and colon-cancer chemoprevention Lancet Oncol. 3 2002 166 174
7. Y.I. Cha, L. Solnica-Krezel, and R.N. DuBois Fishing for prostanoids: deciphering the developmental functions of cyclooxygenase-derived prostaglandins Dev. Biol. 289 2006 263 272 (Pubitemid 43049931)
8. W.L. Smith, D.L. DeWitt, and R.M. Garavito Cyclooxygenases: structural, cellular, and molecular biology Annu. Rev. Biochem. 69 2000 145 182
9. T. Hla, and K. Neilson Human cyclooxygenase-2 cDNA Proc. Natl. Acad. Sci. U. S. A. 89 1992 7384 7388
10. D.A. Jones, D.P. Carlton, T.M. McIntyre, G.A. Zimmerman, and S.M. Prescott Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines J. Biol. Chem. 268 1993 9049 9054 (Pubitemid 23118701)
11. D.A. Kujubu, B.S. Fletcher, B.C. Varnum, R.W. Lim, and H.R. Herschman TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue J. Biol. Chem. 266 1991 12866 12872
12. C.S. Williams, W. Smalley, and R.N. DuBois Aspirin use and potential mechanisms for colorectal cancer prevention J. Clin. Invest. 100 1997 1325 1329 (Pubitemid 27425755)
13. W.L. Xie, J.G. Chipman, D.L. Robertson, R.L. Erikson, and D.L. Simmons Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing Proc. Natl. Acad. Sci. U. S. A. 88 1991 2692 2696 (Pubitemid 21916484)
14. C.E. Eberhart, R.J. Coffey, A. Radhika, F.M. Giardiello, S. Ferrenbach, and R.N. DuBois Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas Gastroenterology 107 1994 1183 1188 (Pubitemid 24294584)
15. A. Greenhough, H.J. Smartt, A.E. Moore, H.R. Roberts, A.C. Williams, C. Paraskeva, and A. Kaidi The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment Carcinogenesis 30 2009 377 386
16. M. Oshima, J.E. Dinchuk, S.L. Kargman, H. Oshima, B. Hancock, E. Kwong, J.M. Trzaskos, J.F. Evans, and M.M. Taketo Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2) Cell 87 1996 803 809 (Pubitemid 26404280)
17. P.C. Chulada, M.B. Thompson, J.F. Mahler, C.M. Doyle, B.W. Gaul, C. Lee, H.F. Tiano, S.G. Morham, O. Smithies, and R. Langenbach Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice Cancer Res. 60 2000 4705 4708
18. T.W. Davis, J.M. O'Neal, M.D. Pagel, B.S. Zweifel, P.P. Mehta, D.M. Heuvelman, and J.L. Masferrer Synergy between celecoxib and radiotherapy results from inhibition of cyclooxygenase-2-derived prostaglandin E2, a survival factor for tumor and associated vasculature Cancer Res. 64 2004 279 285 (Pubitemid 38114108)
19. Y. Sun, X.M. Tang, E. Half, M.T. Kuo, and F.A. Sinicrope Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells Cancer Res. 62 2002 6323 6328 (Pubitemid 35244488)
20. Z. Xu, S. Choudhary, O. Voznesensky, M. Mehrotra, M. Woodard, M. Hansen, H. Herschman, and C. Pilbeam Overexpression of COX-2 in human osteosarcoma cells decreases proliferation and increases apoptosis Cancer Res. 66 2006 6657 6664 (Pubitemid 44085622)
21. E. Kassi, T.G. Sourlingas, M. Spiliotaki, Z. Papoutsi, H. Pratsinis, N. Aligiannis, and P. Moutsatsou Ursolic acid triggers apoptosis and Bcl-2 downregulation in MCF-7 breast cancer cells Cancer Invest. 27 2009 723 733
22. K. Subbaramaiah, P. Michaluart, M.B. Sporn, and A.J. Dannenberg Ursolic acid inhibits cyclooxygenase-2 transcription in human mammary epithelial cells Cancer Res. 60 2000 2399 2404 (Pubitemid 30262429)
23. D. Andersson, J.J. Liu, A. Nilsson, and R.D. Duan Ursolic acid inhibits proliferation and stimulates apoptosis in HT29 cells following activation of alkaline sphingomyelinase Anticancer Res. 23 2003 3317 3322 (Pubitemid 36975429)
24. Y. Li, D. Xing, Q. Chen, and W.R. Chen Enhancement of chemotherapeutic agent-induced apoptosis by inhibition of NF-kappaB using ursolic acid Int. J. Cancer 127 2010 462 473
25. Y.X. Zhang, C.Z. Kong, L.H. Wang, J.Y. Li, X.K. Liu, B. Xu, C.L. Xu, and Y.H. Sun Ursolic acid overcomes Bcl-2-mediated resistance to apoptosis in prostate cancer cells involving activation of JNK-induced Bcl-2 phosphorylation and degradation J. Cell Biochem. 109 2010 764 773
26. D. Andersson, Y. Cheng, and R.D. Duan Ursolic acid inhibits the formation of aberrant crypt foci and affects colonic sphingomyelin hydrolyzing enzymes in azoxymethane-treated rats J. Cancer Res. Clin. Oncol. 134 2008 101 107 (Pubitemid 350060690)
27. L. Yang, X. Liu, Z. Lu, C.J. Yuet-Wa, L. Zhou, K.P. Fung, P. Wu, and S. Wu Ursolic acid induces doxorubicin-resistant HepG2 cell death via the release of apoptosis-inducing factor Cancer Lett. 298 2010 128 138
28. J.Z. Shan, Y.Y. Xuan, S. Zheng, Q. Dong, and S.Z. Zhang Ursolic acid inhibits proliferation and induces apoptosis of HT-29 colon cancer cells by inhibiting the EGFR/MAPK pathway J. Zhejiang. Univ. Sci. B. 10 2009 668 674
29. A. Najid, A. Simon, J. Cook, H. Chable-Rabinovitch, C. Delage, A.J. Chulia, and M. Rigaud Characterization of ursolic acid as a lipoxygenase and cyclooxygenase inhibitor using macrophages, platelets and differentiated HL60 leukemic cells FEBS Lett. 299 1992 213 217
30. D. Es-Saady, A. Simon, M. Ollier, J.C. Maurizis, A.J. Chulia, and C. Delage Inhibitory effect of ursolic acid on B16 proliferation through cell cycle arrest Cancer Lett. 106 1996 193 197 (Pubitemid 126745145)
31. P.O. Harmand, R. Duval, C. Delage, and A. Simon Ursolic acid induces apoptosis through mitochondrial intrinsic pathway and caspase-3 activation in M4Beu melanoma cells Int. J. Cancer 114 2005 1 11 (Pubitemid 40194303)
32. F. Lauthier, L. Taillet, P. Trouillas, C. Delage, and A. Simon Ursolic acid triggers calcium-dependent apoptosis in human daudi cells Anticancer Drugs 11 2000 737 745
33. D.Y. Leger, B. Liagre, and J.L. Beneytout Low dose leflunomide activates PI3K/Akt signaling in erythroleukemia cells and reduces apoptosis induced by anticancer agents Apoptosis 11 2006 1747 1760 (Pubitemid 44371050)
34. T.E. Crew, D.J. Elder, and C. Paraskeva A cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: regulation of COX-2 by butyrate Carcinogenesis 21 2000 69 77 (Pubitemid 30064146)
35. Y. Sun, J. Chen, and B. Rigas Chemopreventive agents induce oxidative stress in cancer cells leading to COX-2 overexpression and COX-2-independent cell death Carcinogenesis 30 2009 93 100
36. H. Allgayer Review article: mechanisms of action of mesalazine in preventing colorectal carcinoma in inflammatory bowel disease Aliment. Pharmacol. Ther. 18 Suppl. 2 2003 10 14 (Pubitemid 37174711)
37. E. Looby, M.M. bdel-Latif, V. thie-Morales, S. Duggan, A. Long, and D. Kelleher Deoxycholate induces COX-2 expression via Erk1/2-, p38-MAPK and AP-1-dependent mechanisms in esophageal cancer cells BMC. Cancer 9 2009 190
38. T. Yang, Y. Huang, L.E. Heasley, T. Berl, J.B. Schnermann, and J.P. Briggs MAPK mediation of hypertonicity-stimulated cyclooxygenase-2 expression in renal medullary collecting duct cells J. Biol. Chem. 275 2000 23281 23286 (Pubitemid 30646228)
39. F.A. Sinicrope, and S. Gill Role of cyclooxygenase-2 in colorectal cancer Cancer Metastasis Rev. 23 2004 63 75 (Pubitemid 38221596)
40. S.L. Kargman, G.P. O'Neill, P.J. Vickers, J.F. Evans, J.A. Mancini, and S. Jothy Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer Cancer Res. 55 1995 2556 2559
41. W. Kutchera, D.A. Jones, N. Matsunami, J. Groden, T.M. McIntyre, G.A. Zimmerman, R.L. White, and S.M. Prescott Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect Proc. Natl. Acad. Sci. U. S. A. 93 1996 4816 4820 (Pubitemid 26162834)
42. S. Pugh, and G.A. Thomas Patients with adenomatous polyps and carcinomas have increased colonic mucosal prostaglandin E2 Gut 35 1994 675 678 (Pubitemid 24163797)
43. B. Rigas, I.S. Goldman, and L. Levine Altered eicosanoid levels in human colon cancer J. Lab. Clin. Med. 122 1993 518 523 (Pubitemid 23352474)
44. H. Sano, Y. Kawahito, R.L. Wilder, A. Hashiramoto, S. Mukai, K. Asai, S. Kimura, H. Kato, M. Kondo, and T. Hla Expression of cyclooxygenase-1 and -2 in human colorectal cancer Cancer Res. 55 1995 3785 3789
45. M.A. Bachelor, A.L. Silvers, and G.T. Bowden The role of p38 in UVA-induced cyclooxygenase-2 expression in the human keratinocyte cell line, HaCaT Oncogene 21 2002 7092 7099 (Pubitemid 35252983)
46. J.L. Dean, M. Brook, A.R. Clark, and J. Saklatvala p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes J. Biol. Chem. 274 1999 264 269 (Pubitemid 29035058)
47. M. Lasa, K.R. Mahtani, A. Finch, G. Brewer, J. Saklatvala, and A.R. Clark Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated protein kinase p38 signaling cascade Mol. Cell Biol. 20 2000 4265 4274 (Pubitemid 30346621)
48. S.H. Ridley, J.L. Dean, S.J. Sarsfield, M. Brook, A.R. Clark, and J. Saklatvala A p38 MAP kinase inhibitor regulates stability of interleukin-1-induced cyclooxygenase-2 mRNA FEBS Lett. 439 1998 75 80 (Pubitemid 28537867)
49. Z. Zhang, H. Sheng, J. Shao, R.D. Beauchamp, and R.N. DuBois Posttranscriptional regulation of cyclooxygenase-2 in rat intestinal epithelial cells Neoplasia 2 2000 523 530 (Pubitemid 32098687)
50. F.M. Giardiello, R.A. Casero Jr., S.R. Hamilton, L.M. Hylind, J.D. Trimbath, D.E. Geiman, K.R. Judge, W. Hubbard, G.J. Offerhaus, and V.W. Yang Prostanoids, ornithine decarboxylase, and polyamines in primary chemoprevention of familial adenomatous polyposis Gastroenterology 126 2004 425 431 (Pubitemid 38182299)
51. M. Stolina, S. Sharma, Y. Lin, M. Dohadwala, B. Gardner, J. Luo, L. Zhu, M. Kronenberg, P.W. Miller, J. Portanova, J.C. Lee, and S.M. Dubinett Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis J. Immunol. 164 2000 361 370 (Pubitemid 30013010)
52. O.C. Trifan, R.M. Smith, B.D. Thompson, and T. Hla Overexpression of cyclooxygenase-2 induces cell cycle arrest. Evidence for a prostaglandin- independent mechanism J. Biol. Chem. 274 1999 34141 34147 (Pubitemid 129511751)
53. G. Zahner, G. Wolf, M. Ayoub, R. Reinking, U. Panzer, S.J. Shankland, and R.A. Stahl Cyclooxygenase-2 overexpression inhibits platelet-derived growth factor-induced mesangial cell proliferation through induction of the tumor suppressor gene p53 and the cyclin-dependent kinase inhibitors p21waf-1/cip-1 and p27kip-1 J. Biol. Chem. 277 2002 9763 9771 (Pubitemid 34968079)
54. K. Mizuno, S. Yamamoto, and W.E. Lands Effects of non-steroidal anti-inflammatory drugs on fatty acid cyclooxygenase and prostaglandin hydroperoxidase activities Prostaglandins 23 1982 743 757 (Pubitemid 12046653)
55. C.A. Rouzer, and L.J. Marnett Mechanism of free radical oxygenation of polyunsaturated fatty acids by cyclooxygenases Chem. Rev. 103 2003 2239 2304
56. D. Wang, and R.N. DuBois Prostaglandins and cancer Gut 55 2006 115 122 (Pubitemid 41820645)